XML 41 R15.htm IDEA: XBRL DOCUMENT

Revenue

6 Months Ended

Jun. 30, 2023

Revenue.

Revenue

Note 10 - Revenue

Revenue classified by commodity, geography and type comprised the following:


		For the three months ended								For the six months ended
		June 30,								June 30,
		2023				2022				2023				2022
Commodity
Gold⁽¹⁾		$	213.9			$	190.7			$	386.1			$	378.2
Silver			35.4				35.8				64.0				76.9
Platinum group metals⁽¹⁾			9.9				17.3				21.3				31.5
Iron ore⁽²⁾			10.1				14.6				23.2				33.9
Other mining assets			5.1				2.4				7.1				3.5
Mining		$	274.4			$	260.8			$	501.7			$	524.0
Oil		$	36.9			$	46.2			$	64.0			$	85.2
Gas			14.2				37.9				31.1				67.4
Natural gas liquids			4.4				7.4				9.4				14.5
Energy		$	55.5			$	91.5			$	104.5			$	167.1
		$	329.9			$	352.3			$	606.2			$	691.1
Geography
South America		$	106.0			$	89.2			$	185.2			$	191.4
Central America & Mexico			86.3				84.5				157.2				163.7
United States			57.8				88.5				108.1				161.6
Canada⁽¹⁾⁽²⁾			43.1				60.7				86.9				112.4
Rest of World			36.7				29.4				68.8				62.0
		$	329.9			$	352.3			$	606.2			$	691.1
Type
Revenue-based royalties		$	99.8			$	130.9			$	191.2			$	252.2
Streams⁽¹⁾			201.4				181.3				358.6				365.5
Profit-based royalties			15.3				27.6				32.5				52.4
Other⁽²⁾			13.4				12.5				23.9				21.0
		$	329.9			$	352.3			$	606.2			$	691.1

1.

For Q2 2023, revenue includes a gain of $0.1 million and loss of $0.2 million for provisional pricing adjustments for gold and platinum group metals, respectively (Q2 2022 – losses of $0.3 million and $0.2 million, respectively). For H1 2023, revenue includes a gain of $0.2 million and $0.3 million of provisional pricing adjustments for gold and platinum group metals, respectively (H1 2022 – a loss of $0.4 million and a gain of $0.4 million, respectively).

2.

For Q2 2023, revenue includes dividend income of $3.1 million from the Company’s equity investment in LIORC (Q2 2022 – $4.5 million). For H1 2023, revenue includes dividend income of $5.4 million from the Company’s equity investment in LIORC (H1 2022 – $7.0 million).